All Stories

  1. A novel Mediterranean diet-inspired supplement reduces hippocampal amyloid deposits and microglial activation through the modulation of the microbiota gut-brain axis in 5xFAD mice
  2. Building a roadmap to nutrition for Healthy Ageing: a brief report on the ILSI Europe Healthy Ageing Task Force
  3. A standardised saffron extract improves subjective and objective sleep quality in healthy older adults with sleep complaints: results from the Gut-Sleep-Brain Axis randomised, double-blind, placebo-controlled pilot study
  4. Dietary substances and their glucuronides: structures, occurrence and biological activity
  5. Dietary (Poly)phenols and the Gut–Brain Axis in Ageing
  6. Stimulation of the Pro-Resolving Receptor Fpr2 Reverses Inflammatory Microglial Activity by Suppressing NFκB Activity
  7. Regulation of Physiological Barrier Function by the Commensal Microbiota
  8. Promiscuous Receptors and Neuroinflammation: The Formyl Peptide Class
  9. A host–gut microbial amino acid co-metabolite, p-cresol glucuronide, promotes blood–brain barrier integrity in vivo
  10. A host–gut microbial co-metabolite of aromatic amino acids, p-cresol glucuronide, promotes blood–brain barrier integrity in vivo
  11. Impact of metabolic disorders on the structural, functional, and immunological integrity of the blood‐brain barrier: Therapeutic avenues
  12. Regulation of blood–brain barrier integrity by microbiome-associated methylamines and cognition by trimethylamine N-oxide
  13. Exploiting formyl peptide receptor 2 to promote microglial resolution: a new approach to Alzheimer’s disease treatment
  14. Analysis of circulating protein aggregates as a route of investigation into neurodegenerative disorders
  15. Activation of the pro-resolving receptors Fpr2/3 attenuate lipopolysaccharide-induced inflammatory microglial activation
  16. Reversal of β-Amyloid-Induced Microglial Toxicity In Vitro by Activation of Fpr2/3
  17. Immuno-metabolic impact of the multiple sclerosis patients’ sera on endothelial cells of the blood-brain barrier
  18. Analysis of circulating protein aggregates reveals pathological hallmarks of amyotrophic lateral sclerosis
  19. Reversal of β-amyloid induced microglial toxicity in vitro by activation of Fpr2/3
  20. Annexin A1 drives macrophage skewing to accelerate muscle regeneration through AMPK activation
  21. Modeling Cardiac Dysfunction Following Traumatic Hemorrhage Injury: Impact on Myocardial Integrity
  22. Desmoglein-3 acts as a pro-survival protein by suppressing reactive oxygen species and doming whilst augmenting the tight junctions in MDCK cells
  23. Estrogen Promotes Pro-resolving Microglial Behavior and Phagocytic Cell Clearance Through the Actions of Annexin A1
  24. Estrogen promotes pro-resolving microglial behaviour and phagocytic cell clearance through the actions of annexin A1:
  25. Activin subfamily peptides predict chronological age in humans
  26. Microbiome–host systems interactions: protective effects of propionate upon the blood–brain barrier
  27. A chemical produced by gut bacteria can help protect the blood–brain barrier
  28. The restorative role of annexin A1 at the blood–brain barrier
  29. Counteractive effects of antenatal glucocorticoid treatment on D1 receptor modulation of spatial working memory
  30. Estrogen protects the blood–brain barrier from inflammation-induced disruption and increased lymphocyte trafficking
  31. Definition of a Novel Pathway Centered on Lysophosphatidic Acid To Recruit Monocytes during the Resolution Phase of Tissue Inflammation
  32. Sex-specific disruption of murine midbrain astrocytic and dopaminergic developmental trajectories following antenatal GC treatment
  33. Astroglial Plasticity Is Implicated in Hippocampal Remodelling in Adult Rats Exposed to Antenatal Dexamethasone
  34. Nonredundant protective properties of FPR2/ALX in polymicrobial murine sepsis
  35. Sex-dependent diversity in ventral tegmental dopaminergic neurons and developmental programing: A molecular, cellular and behavioral analysis
  36. Identification of a Novel Recycling Sequence in the C-tail of FPR2/ALX Receptor
  37. Endogenous annexin A1 is a novel protective determinant in nonalcoholic steatohepatitis in mice
  38. Ligand-specific conformational change of the G-protein–coupled receptor ALX/FPR2 determines proresolving functional responses
  39. Chemerin15 inhibits neutrophil-mediated vascular inflammation and myocardial ischemia-reperfusion injury through ChemR23
  40. Antenatal Glucocorticoid Treatment Induces Adaptations in Adult Midbrain Dopamine Neurons, which Underpin Sexually Dimorphic Behavioral Resilience
  41. Oestrogen and immunomodulation: new mechanisms that impact on peripheral and central immunity
  42. Prazosin, an α1-adrenoceptor antagonist, prevents memory deterioration in the APP23 transgenic mouse model of Alzheimer's disease
  43. Identification of an essential endogenous regulator of blood–brain barrier integrity, and its pathological and therapeutic implications
  44. Annexin A1 N-Terminal Derived Peptide Ac2-26 Exerts Chemokinetic Effects on Human Neutrophils
  45. Novel Ontogenetic Patterns of Sexual Differentiation in Arcuate Nucleus GHRH Neurons Revealed in GHRH-Enhanced Green Fluorescent Protein Transgenic Mice
  46. Peripheral vs. Central Sex Steroid Hormones in Experimental Parkinson?s Disease
  47. Annexin A1: A Central Player in the Anti-Inflammatory and Neuroprotective Role of Microglia
  48. Anti-allergic drugs and the Annexin-A1 system
  49. Estrogen Actions in the Brain and the Basis for Differential Action in Men and Women: A Case for Sex-Specific Medicines
  50. Independent influences of sex steroids of systemic and central origin in a rat model of Parkinson's disease: A contribution to sex-specific neuroprotection by estrogens
  51. Annexin A1 regulates hormone exocytosis through a mechanism involving actin reorganization
  52. Cromoglycate drugs suppress eicosanoid generation in U937 cells by promoting the release of Anx-A1
  53. Annexin A1 in the brain – undiscovered roles?
  54. Striatal susceptibility to a dopaminergic neurotoxin is independent of sex hormone effects on cell survival and DAT expression but is exacerbated by central aromatase inhibition
  55. The Size and Distribution of Midbrain Dopaminergic Populations are Permanently Altered by Perinatal Glucocorticoid Exposure in a Sex- Region- and Time-Specific Manner
  56. Perinatal Glucocorticoid Treatment Disrupts the Hypothalamo-Lactotroph Axis in Adult Female, But Not Male, Rats
  57. Altered Mesencephalic Dopaminergic Populations in Adulthood as a Consequence of Brief Perinatal Glucocorticoid Exposure
  58. Sex dimorphisms in the neuroprotective effects of estrogen in an animal model of Parkinson's disease
  59. Dose- and sex-dependent effects of the neurotoxin 6-hydroxydopamine on the nigrostriatal dopaminergic pathway of adult rats: differential actions of estrogen in males and females